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“Chronic traumatic encephalopathy” (CTE) is described as a slowly progressive
neurodegenerative disease believed to result from multiple concussions. Traditionally,
concussions were considered benign events and although most people recover fully,
about 10% develop a post-concussive syndrome with persisting neurological, cognitive
and neuropsychiatric symptoms. CTE was once thought to be unique to boxers, but it has
now been observed in many different athletes having suffered multiple concussions as
well as in military personal after repeated blast injuries. Much remains unknown about
the development of CTE but its pathological substrate is usually tau, similar to that seen
in Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD). The aim of
this “perspective” is to compare and contrast clinical and pathological CTE with the
other neurodegenerative proteinopathies and highlight that there is an urgent need for
understanding the relationship between concussion and the development of CTE as it
may provide a window into the development of a proteinopathy and thus new avenues for
treatment.
Keywords: concussions, chronic traumatic encephalopathy, neurodegenerative disease, Alzheimer’s disease,
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CONCUSSIONS: AN EVOLUTION IN OUR UNDERSTANDING
“Chronic traumatic encephalopathy” (CTE) is described as a
slowly progressive neurodegenerative disease with pathological
tau accumulation at the depths of the sulci in superficial layers
of the cortex. Clinically CTE is believed to include neuropsy-
chiatric, cognitive and motor deficits that manifest years after
implicated concussive or subconcussive events (McKee et al.,
2009). It is believed to be a consequence of repeated mild brain
traumas also known as concussions. Although the majority of
concussions are fully resolved within 3 months (Iverson, 2007),
and conventional neuroimaging and neuropsychological testing
are typically normal (Broglio and Puetz, 2008), the notion of
concussion as a completely benign event (e.g., “bell-ringer”) is
outdated. Most people return to baseline after a single concus-
sion but an estimated 10% of cases result in serious and persisting
somatic, affective, cognitive, and/or movement sequelae (Wood,
2004). There is growing clinical and societal concern about the
effects ofmultiple concussions (Jordan, 2013) although onemeta-
analyses revealed no significant effects after multiple concussions
(Belanger et al., 2010). CTE was first described in Miller (1966)
as a constellation of symptoms typical of neurodegenerative dis-
ease. Clinically and pathologically it bears resemblance to other
neurodegenerative diseases, now thought of as proteinopathies,
which includes Alzheimer’s disease (AD) and frontotemporal
lobar degeneration (FTLD). Although widespread media atten-
tion has spawned a dogma on the delayed effects of multiple
concussions (Corsellis and Brierley, 1959; Corsellis et al., 1973;
Omalu et al., 2005, 2010a; Gavett et al., 2010; Costanza et al., 2011;
Stern et al., 2011; Goldstein et al., 2012; McKee et al., 2013), there
remainsmuch to be known on the clinical and pathophysiology of
CTE. A better understanding of the differences and similarities of
CTE and the other proteinopathies may help guide future studies.
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MULTIPLE CONCUSSIONS AND CHRONIC TRAUMATIC
ENCEPHALOPATHY
PUNCH DRUNK SYNDROME, DEMENTIA PUGILISTICA, CHRONIC
TRAUMATIC ENCEPHALOPATHY
In 1928, Martland introduced the term “punch-drunk” state
(Martland, 1928) in reference to the chronic motor and psychi-
atric consequences of blows to the head in boxing. Millspaugh
(1937) coined “dementia pugilistica” to describe similar cases.
A few decades later, Critchley (1957) reported on 69 cases
of progressive neurological disease in boxers and proposed
“chronic progressive traumatic encephalopathy of boxers.” He
described an insidious and gradual development of mental
and physical anomalies marked by a “euphoric dementia” with
emotional lability, little insight, progressive bradyphrenia, and
memory deficits, along with changes in behavior. Critchley added
that many patients displayed mood-swings, intense irritabil-
ity, and occasionally, uninhibited violent behavior. He noted
“fatuous cheerfulness” as the commonest mood finding but
also reported paranoid depression. Motor findings included
pyramidal, extra-pyramidal, and cerebellar signs, with tremor
and dysarthria the most frequently reported. Sensory percep-
tual findings included deafness and poor vision. His patients
also complained of persistent dull headaches, postural dizzi-
ness, and unsteady gait, reminiscent of acute concussion and
post-concussive syndrome. In 1969, Roberts reported on 224
former boxers and found that 17% suffered from significant
memory loss, aggression, confusion, or depression and that there
was direct correlation of incidence to number of fights and
overall length of boxing career (Roberts, 1969). Many obser-
vational studies, some prospective, have also been undertaken,
including a systematic review of 36 of an initial 943 studies
on the chronic effects of amateur boxing (Loosemore et al.,
2007).
The early literature on the chronic effects of multiple con-
cussions focused on boxing, but multiple concussions sustained
under different circumstances can also produce chronic effects.
The term CTE has been coined to encompass progressive neu-
rodegenerative effects observed after multiple concussions sus-
tained in any context (Miller, 1966).
Clinical CTE cases overlap with punch-drunk syndrome.
CTE is usually described as an evolving constellation of cog-
nitive, psychiatric and motor symptoms (McKee et al., 2009).
Cognitive findings may precede, co-occur or follow psychi-
atric findings, and can include impaired concentration, atten-
tion, and memory along with disorientation, confusion, and
speech abnormalities later on McKee et al. (2009). Emotional
lability, inappropriate behavior, paranoia, outbursts of aggres-
sive behavior and explosivity, mood disturbance, disinhibition,
psychosis, and dysexecutive symptoms are observed. Dizziness
and headaches are frequent (McKee et al., 2009). Psychiatric
symptoms are observable at all stages of CTE, with no clear
dose response between extent of neuropathology and clin-
ical symptoms (McKee et al., 2013). Parkinsonian symp-
toms of tremor, masked facies, wide based gait, poor speech,
ocular abnormalities, bradykinesia, and dementia appear as
the disease progresses (Omalu et al., 2011a; McKee et al.,
2013).
WHO IS AT RISK?
Themajority of cases of suspected CTE have been reported in ath-
letes in contact sports, including boxing, hockey, wrestling, soccer,
and North American football (Corsellis et al., 1973; Omalu et al.,
2006, 2010b; McKee et al., 2009; Dekosky et al., 2010; Gavett et al.,
2011; Neselius et al., 2012). CTE has also been associated with
physical abuse and epilepsy (McKee et al., 2009). More recently,
CTE was reported in a war veteran having suffered blast-injury
without signs of overt concussion (Omalu et al., 2011b).
CTE requires post-mortem assessment and all post-mortem
studies to date contain samples that are not representative of
either the general population or even of multiply concussed pop-
ulations. McKee et al. (2009) reported that 46/51 (90%) of neu-
ropathologically confirmed CTE cases occurred in athletes who
had played contact sports. However, in general, brains referred for
autopsy are those of individuals who displayed overt neurologi-
cal signs at the time of death and therefore were at elevated risk
of underlying pathology compared to the large number of ath-
letes who play contact sports but do not show neurological signs
throughout their life.
McKee et al. (2013) recently published an expansion of
her previous study with 85 brains from former athletes, vet-
erans and civilians with a history of multiple concussions.
Importantly, there was no evidence of CTE despite repeti-
tive concussion in 17/85 (20%) of cases, and in 15/85 cases
(37%) there was significant comorbid pathology of AD, Lewy
body disease (LBD), motor neuron disease (MND), or FTLD.
In advanced cases, a comorbid condition such as AD, LBD,
or FTLD was present in almost half the cases (10/25) These
findings converge with a recent study undertaken by our
group, which showed that even with a history of multiple
concussions from contact sport and a positive clinical pre-
sentation before death, a diagnosis of CTE is not inevitable
on neuropathological examination. Our case series included
the brains of six retired professional players of the Canadian
Football League with a history of multiple concussions (Hazrati
et al., 2013) and all clinically symptomatic before death. While
each case displayed significant neuropathological changes on
post-mortem examination, only three showed pathology con-
sistent with CTE. In the other three cases, the neuropatho-
logical diagnoses were Parkinson’s Disease (PD), Amyotrophic
Lateral Sclerosis (ALS), and AD. Even the cases with CTE
had co-pathology, including AD, PD, or vasculopathy. This
study demonstrates that there is not always a direct rela-
tionship between multiple concussions, clinical symptomology,
and CTE.
In a recent retrospective analysis a higher incidence of mortal-
ity from neurodegenerative disease including AD- and ALS was
reported among former National Football League players, com-
pared to the general population (Lehman et al., 2012). Notably,
however, players (vs. the rest of the general US population stud-
ied), and in particular players in speed positions, showed the
lowest death rate for other causes of death including cardiovas-
cular disease and cancer, the largest killers of the general US
population. These data may thus inflate the apparent risk of neu-
rodegenerative disease and argue for prospective research into the
biological effects of multiple concussions.
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AGE OF ONSET
Critchley (1957) reports age of onset on 11 cases of punch-drunk
syndrome: two were still boxing, six were in their 20 s, two were
in their 30 s, and one was 61 years old. McKee et al. (2009)
reported CTE symptom onset at ages ranging from 25 to 76 years;
one-third were symptomatic at retirement and half were symp-
tomatic within 4 years of their retirement. Although Omalu et al.
(2011a) proposed an asymptomatic period between playing of the
sport and symptom onset, in his series of 10 cases, four were
in their 30 s, three were in their 40 s, and three were in their
50 s. Thus, very few of the players had a prolonged asymptomatic
or latent period. There has been no differentiation between the
delayed onset of CTE-associated symptoms and the more imme-
diate onset observed in boxers. Importantly, in the absence of
serial, longitudinal evaluations in the above studies, we cannot
rule out symptom onset prior to formal diagnosis.
Whether CTE and the punch-drunk syndrome are dissociable
entities is still unclear. While both syndromes can be associated
with the cumulative effects of concussion, it is conceivable that
CTE reflects a delayed onset entity, while the punch-drunk syn-
drome represents a continuation and progression of symptoms
from an acute concussive state (Gardner et al., 2014). Also uncer-
tain is whether some players are in a prolonged or more severe
postconcussive syndrome that may have a different pathophysiol-
ogy than the players who develop symptoms decades after their
last concussion.
CHRONIC TRAUMATIC ENCEPHALOPATHY vs. OTHER
PROTEINOPATHIES
CLINICAL COMPARISONS
The clinical diagnosis of CTE is currently not feasible due to the
overlap with other neurodegenerative conditions. AD is the most
common neurodegenerative disease in those over age 65 (Prince
et al., 2013) and most often presents with impaired learning and
recall of recently learned information (McKhann et al., 2011).
Neuropsychiatric symptoms including depression, apathy, agita-
tion, and irritability, as in CTE, are not uncommon (Cummings,
1997).
FTLD is the most common neurodegenerative disease in those
less than 65, and includes several clinical syndromes involv-
ing changes in behavior, language, and motor function. The
main clinical phenotypes are: behavioral variant frontotempo-
ral dementia (bvFTD), primary progressive aphasia, FTD-motor
neuron disease (FTD-MND), progressive supranuclear palsy
(PSP), and corticobasal syndrome (CBS). Although these syn-
dromes strongly overlap in clinical, genetic, and pathological fea-
tures their syndrome specific clinical expression differs markedly
due to focal pathology (Brun, 1993) (Figure 1A). bvFTD, as its
name implies, is primarily a behavioral syndrome characterized
by dramatic personality and behavioral changes. The apathy,
loss of social norms, and decreased empathy seen in bvFTD are
frequent symptoms in traumatic brain injury (TBI) including
moderate-severe TBI, concussion, and CTE and are attributed to
frontal lobe degeneration (Damasio et al., 1991; Stuss et al., 2001;
Jordan, 2013) in particular orbitofrontal and ventromedial pre-
frontal cortex, as well as insula (Rosen et al., 2005). The language
variants, as well as CBS (a progressive, asymmetric, akinetic-rigid
FIGURE 1 | The interrelationships between concussion,
post-concussion syndrome (PCS), chronic traumatic encephalopathy
(CTE), and all the neurodegenerative diseases. (A) There is considerable
symptom overlap between concussion, PCS, CTE, and the
neurodegenerative diseases. (B) Pathologically the relationship between
concussion, PCS, CTE, and all the neurodegenerative diseases is unclear. In
CTE there is substantial evidence for overlapping pathology of tau, TDP-43,
amyloid, and alpha-synuclein with neurodegenerative diseases. In
neurodegenerative diseases such as AD, PD, and LBD, there is also
overlapping pathology. The pathology of concussion and PCS and their
relationship to CTE remains to be explored. AD, Alzheimer’s Disease;
ALS-PDC, amyotrophic lateral sclerosis-parkinson’s dementia complex
(Guam); CBD, corticobasal degeneration; CBS, corticobasal syndrome; CTE,
chronic traumatic encephalopathy; LBD, Lewy Body Disease; FTD,
frontotemporal dementia; MND, motor neuron disease; PCS,
Post-concussive syndrome; PSP, progressive supranuclear palsy; PD,
Parkinson’s disease. “?” indicates uncertainty about overlap.
syndrome) and PSP (cognitive and behavioral deficits and promi-
nent oculomotor and movement impairments) (Litvan et al.,
1996) have less in common with CTE. bvFTD-like symptoms can
co-occur in patients with MND (Lomen-Hoerth et al., 2003), and
some patients with CTE have presented with MND phenotype
and a TAR-DNA binding protein 43 (TDP-43) pathology (McKee
et al., 2010). Parkinsonism and cognitive deficits as seen in LBD
and PD are also seen in CTE and there are cases of LBD and PD
subsequent to multiple concussions (Hazrati et al., 2013; McKee
et al., 2013).
The overlap in signs and symptoms of CTE and other neu-
rodegenerative diseases, especially bvFTD, is likely a result of
focal involvement of frontal networks that subserve numer-
ous higher functions including personality/emotional life, exec-
utive function, and motivation (Stuss and Levine, 2002). A
better understanding of the pathophysiology of any of the neu-
rodegenerative diseases may shed light on the risk factors for
developing CTE.
PATHOLOGICAL SIGNS OF CTE vs. OTHER NEURODEGENERATIVE
DISEASE
Only a limited number of cases of suspected CTE have undergone
pathological examination but post-mortem assessments show a
distinct pattern from other proteinopathies including dilated ven-
tricles, a fenestrated, and cavum septum pellucidum, significant
atrophy of the medial temporal lobes, thalamus, and mammillary
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bodies and occasionally pallor of the locus coeruleus and sub-
stantia nigra (McKee et al., 2009; Gavett et al., 2011; Stern
et al., 2011). Hyperphosphorylated tau deposits in neurons of
specific areas of the brains of boxers and professional football
players, thus adding CTE to the list of known tauopathies that
includes PSP, CBD, FTLD, Guam-Parkinson Dementia Complex,
and AD. Tau is a protein that binds to and stabilizes microtubules
required for maintaining neuronal shape and for transport of
cellular cargo (Brunden et al., 2009). The distribution of these
pathological changes is along the amygdalo-hippocampal-septo-
hypothalamic-mesencephalic continuum, which is part of the
emotional or visceral brain (McKee et al., 2009). The pathological
changes are greatest in the depths of sulci, perivascularly around
small vessels, and in the superficial cortical layers (II/III). This tau
distribution pattern is distinct from other tauopathies. In AD, the
neurofibrillary tangles (NFTs) are more regular, are primarily in
layers III and V of the cortex, and are neither perivascular nor pri-
marily at the depths of the sulci. In PSP, the NFTs aremainly in the
basal ganglia and hindbrain structures. Other distinguishing pat-
terns of tau deposition seen in CTE include irregular and patchy
distributions and also prominence in the periventricular and sub-
pial areas. Unlike AD, CTE usually lacks significant amounts of
beta-amyloid plaque deposition (Braak and Braak, 1997; McKee
et al., 2009; Gavett et al., 2011; Stern et al., 2011).
In select cases of CTE, widespread TDP-43 immunopositive
inclusions have been observed (McKee et al., 2010). Lesions
involving the corticospinal tracts and the anterior horns of the
spinal cord are associated with clinical motor findings of spas-
ticity, weakness, and fasciculations similar to those seen in ALS
(McKee et al., 2010). The pathological accumulation of TDP-43
is also seen in FTLD and like tau can cause various FTLD syn-
dromes (Whitwell and Josephs, 2011). Alpha-synuclein positive
Lewy bodies as seen in PD and LBD and Alzheimer’s beta-amyloid
pathology has also occasionally been reported in CTE (McKee
et al., 2013).
Similarities exist between CTE and the chronic effects of mod-
erate and severe TBI, in which there can be neurodegeneration in
the chronic phase months to years after TBI with sub-acute atro-
phy within the hippocampi (Ng et al., 2008) and elsewhere (Green
et al., 2010). Interestingly, the corpus callosum (unmyelinated
axons in particular) is vulnerable to protein deposition post-TBI,
suggesting commonality with CTE (Reeves et al., 2005, 2012).
Recently Omalu et al. (2011a) proposed four histomorpho-
logic phenotypes in CTE based on the distribution of NFTs and
neuritic threads in the cortex, brainstem, subcortical nuclei, basal
ganglia, and cerebellum, and they include amyloid plaques in one
phenotype. In contrast, McKee et al. (2013) proposed a staging
scheme for CTE severity based on tau distribution which would
range from focal epicentres of phosphorylated tau (p-tau) usu-
ally in the frontal cortex and typically around small vessels at
the depths of sulci to widespread p-tau pathology in a patchy
irregular distribution in cortical areas and medial temporal lobe
as well as in thalamus, hypothalamus, mammillary bodies, basal
ganglia, brainstem and in white matter tracts. Currently, the
clinical-pathological relationship is unknown and questions as
to whether differences relate to different types of CTE, differ-
ent types of injury and/or different clinical syndromes remain.
There is some evidence for pathological and clinical differences
between the classic CTE cases and the “modern” form described
in the last few years (Gardner et al., 2014). These authors argue
that the classic form of CTE does not appear to advance in a
predictable and sequential series of stages, and progression of
physical symptoms is only present in approximately one-third
of cases. Clearly long-term, prospective clinical studies followed
by detailed neuropathological examination are needed to help
unravel this issue.
It has become increasingly apparent that CTE frequently coex-
ists with other pathologies. In our series of six cases, the three
patients with CTE also exhibited other neurodegenerative pathol-
ogy as noted above (Hazrati et al., 2013). McKee’s recent case
series (McKee et al., 2013) found co-pathology of CTE with AD,
LBD or both in 17 cases and CTE and MND in eight cases. The
relative contribution of the different pathological substrates to
the clinical symptoms is currently unknown and requires further
study. A recent review of the contemporary cases in the literature
found that over 50% had copathology with CTE and only 20%
had pure CTE (Gardner et al., 2014).
In vivo diagnosis of the specific proteinopathy responsible for
a neurodegenerative disease is now the goal. Currently, amyloid
imaging and cerebrospinal fluid (CSF) biomarkers of amyloid and
tau for the in vivo diagnosis of AD are available although not in
clinical use (Sperling and Johnson, 2013). Regarding the other
neurodegenerative diseases, neither imaging nor fluid biomarkers
are available for their diagnosis although there are some exper-
imental data coming out in PD (Parnetti et al., 2013; Schapira,
2013) and FTLD (Hu et al., 2010, 2013). In CTE, concussion,
and post-concussion syndrome there are a few studies suggesting
abnormalities including elevated levels of CSF tau (Neselius et al.,
2012; Shenton et al., 2012; Zetterberg et al., 2013) but these lack
pathological confirmation and haven’t been reproduced. CTE is
still in its infancy with regard to defining the clinical syndrome
and determining in vivo biomarkers of the underlying pathology.
SUMMARY AND CONCLUSIONS: MUCH REMAINS TO BE
KNOWN
Tau deposition and pathological changes in a particular distri-
bution have been observed in cases of multiple concussions.
The evidence to date concerning CTE, its association with mul-
tiple concussions, and its clinical signs and symptoms comes
from case reports, cases series, and retrospective analyses (Graves
et al., 1990; Schofield et al., 1997; Mehta et al., 1999; McKee
et al., 2013). The symptoms described in CTE overlap with those
described in concussion, PCS and the neurodegenerative diseases.
Figure 1A. There is a selection bias for many of the reported
cases, some died from violent deaths such as suicide or drug
overdose and/or were otherwise clinically symptomatic with cog-
nitive symptoms. There are now an increasing number of reports
of cases with multiple concussions but no evidence of CTE at
autopsy (Hazrati et al., 2013; McKee et al., 2013). The exact
relationship between multiple concussions and CTE is ambigu-
ous. Moreover, one must distinguish clinically and pathologically
between static, non-progressive cumulative effects of multiple
concussions vs. progressive findings of symptomatic neurodegen-
erative disease. Complicating the situation are cases of a single,
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but more serious TBI associated with increased risk of dementia
(Blennow et al., 2012; Sayed et al., 2013) as well as atrophy and
loss of white matter integrity in the sub-acute and chronic stages
of injury (Greenberg et al., 2008; Ng et al., 2008; Whitwell and
Josephs, 2011; Adnan et al., 2013)
Prospective, longitudinal studies with neuropathological anal-
ysis that sample a broader cross section of individuals, including
those with a history of multiple concussions but without positive
clinical neurological findings prior to death are critically needed.
Understanding the relationship of multiple concussions to CTE
as well as possible modifiers is paramount for preventing or ame-
liorating this illness and for finding a cure. Furthermore, and
most importantly, by evoking a diagnosis of CTE as a cause of
the symptoms and signs and symptoms in multiple concussions,
and failing to address treatable and potentially reversible causes of
the suffering is a disservice to the patient and a lost opportunity
to understand their sequelae (Wortzel et al., 2013).
CTE now joins the family of tauopathies that includes PSP,
bvFTD, and AD but there a number of cases of associated TDP
and amyloid pathology, which requires further study and clin-
ical correlate (Figure 1B). As well, the pathological relationship
of CTE with concussion and post-concussion syndrome remains
to be explored. As we move toward protein specific treatments,
in vivo diagnosis of CTE at an early stage will be impera-
tive for implementing appropriate treatments and to delay, halt,
or reverse its progression. In order to do this, good clinical-
pathological studies will be required and appropriate biomarkers
will have to be developed.
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